Acute and preventive treatment of menstrual migraine: a meta-analysis.

ABSTRACT:

Background and objectives

About a quarter of migraine cases among women have menstrual migraine (MM), which is usually more severe, longer lasting, and less responsive to treatment than typical migraine. Randomized controlled trials (RCTs) have evaluated the efficacy of several medication in the acute and preventive treatment of MM; this meta-analysis compared the effectiveness of these treatments.

Methods

We conducted systematic searches in the Cochrane Central Register of Controlled Trials, MEDLINE, and Embase databases. The primary outcomes of acute treatment trials were pain relief at 2 and 24 h after treatment compared with placebo or another treatment. The three endpoints we checked for studying MM prevention were: no recurrence of headaches each month, a 50% reduction

SUBMITTER: Khoo CC 

PROVIDER: S-EPMC11373287 | biostudies-literature | 2024 Sep

REPOSITORIES: biostudies-literature